96971 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-13
ENGINEERED IMMUNOCYTOKINES, FUSION POLYPEPTIDES, AND IL10 POLYPEPTIDES
#2FUSION PROTEIN COMPRISING IL13
#3LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY
#4LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY
#5Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System
#6USES AND METHODS FOR IL-2, IL-13, AND IL-4 CYTOKINE BIFUNCTIONAL MOLECULES
#7GENETICALLY ENGINEERED CELLS AND USES THEREOF
#8mRNA VACCINES COMPRISING IL-4 AND/OR IL-13 RNA AND USES THEREOF
#9TARGETING MODULES AGAINST IL13R-alpha-2 AND/OR HER2 FOR USE IN A METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR-MEDIATED IMMUNE RESPONSE IN A MAMMAL
#10DE NOVO DESIGN OF POTENT AND SELECTIVE INTERLEUKIN MIMETICS
#11METHODS AND COMPOSITIONS FOR TREATING CANCER
#12LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY
#13MSC-NTF SPECIFIC EXOSOMES AND USE THEREOF
#14COMPOSITIONS AND METHODS FOR TREATING FIBROSIS
#15IL-13RALPHA2 TARGETED IMMUNOTOXINS AND METHODS OF USE
#16Ligand discovery and gene delivery via retroviral surface display
#17BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
#18Cancer Stem Cell Targeted Cancer Vaccines
#19VIRUS-LIKE PARTICLES AND METHODS OF PRODUCTION THEREOF
#20De novo design of potent and selective interleukin mimetics
#21GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO
#22Ligand discovery and gene delivery via retroviral surface display
#23DUAL-TARGETING CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS COMPRISING IL-13 AND CHLOROTOXIN FOR CANCER TREATMENT
#24METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA
#25CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING
#26EPHA3 AND MULTI-VALENT TARGETING OF TUMORS
#27Interleukin-9 Signaling in Chimeric Antigen Receptor (CAR) Immune Cells
#28Interleukin-4 Receptor-Binding Fusion Proteins and Uses Thereof
#29De novo design of potent and selective interleukin mimetics
#30FUSION PROTEIN COMPRISING IL13
#31De novo design of potent and selective interleukin mimetics
#32Multi-level specific targeting of cancer cells
#33Therapeutic IL-13 polypeptides
#34Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System
#35Fusion protein comprising IL13
#36IL-13/IL-4 SUPERKINES: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS OF USE THEREOF
#37IMMUNOREACTANT CARRIER
#38Cancer stem cell targeted cancer vaccines
#39MSC-NTF specific exosomes and use thereof
#40IL-13 RECEPTOR ALPHA 2 TARGETED, ZETAKINE DIRECTED T CELL IMMUNOTHERAPY
#41Novel IL-4-/IL-13-derived peptide compounds for the treatment or prevention of neurodegenerative or neuroinflammatory diseases
#42Ligand discovery and gene delivery via retroviral surface display
#43Chimeric immunoreceptor useful in treating human cancers
#44EPHA3 and multi-valent targeting of tumors
#45De novo design of potent and selective interleukin mimetics
#46De novo design of potent and selective interleukin mimetics
#47Expression of metabolic modulators in tumor microenvironment to improve tumor therapy
#48COSTIMULATORY CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING IL13R-alpha-2
#49De novo design of potent and selective interleukin mimetics
#50COMPOSITIONS FOR IMPROVING CAR-T CELL FUNCTIONALITY AND USE THEREOF
#51Multi-level specific targeting of cancer cells
#52IL-13 SUPERKINE: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS OF USE THEREOF
#53Genetically modified non-human animals expressing human EPO
#54De novo design of potent and selective interleukin mimetics
#55METHOD FOR THE PREPARATION AND PROLONGED STORAGE OF GROWTH FACTORS AND CYTOKINES OBTAINED FROM PLATELET RICH PLASMA
#56CYSTEINE VARIANTS OF INTERLEUKIN-11 AND METHODS OF USE THEREOF
#57Compositions and methods for treating fibrosis
#58Multi-level specific targeting of cancer cells
#59Therapeutic IL-13 polypeptides
#60Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient
#61CELL-BASED TARGETED DELIVERY OF PSEUDONOMAS EXOTOXIN
#62Deimmunized therapeutic compositions and methods
#63Costimulatory chimeric antigen receptor T cells targeting IL13Rα2
#64EPHA3 and multi-valent targeting of tumors
#65PROTEIN EXPRESSION ENHANCING POLYPEPTIDES
#66METHODS AND COMPOSITIONS FOR TREATING CANCER
#67Nucleic acids encoding a fusion protein useful for multi-level specific targeting of cancer cells
#68Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11
#69Cytokine-based fusion proteins for treatment of immune disorders
#70Therapeutic IL-13 polypeptides
#71Chimeric Immunoreceptor Useful in Treating Human Cancers
#72Compositions and methods for treating fibrosis
#73Therapeutic IL-13 polypeptides
#74Costimulatory chimeric antigen receptor T cells targeting IL13Rα2
#75EPHA3 And multi-valent targeting of tumors
#76IL-13 receptor binding peptides
#77Chimeric Immunoreceptor Useful in Treating Human Cancers
#78Targeting of herpes simplex virus to specific receptors
#79Methods and compositions for treating cancer
#80Ligation of stapled polypeptides
#81Genetically modified non-human animals expressing human EPO
#82Protein expression enhancing polypeptides
#83Multi-level specific targeting of cancer cells
#84Cancer stem cell targeted cancer vaccines
#85Cytokine-based fusion proteins for treatment of immune disorders
#86Modified IL-13 polypeptides
#87METHOD FOR PRODUCING POLYPEPTIDE FRAGMENT WITH HIGH EFFICIENCY, WHICH IS SUITABLE FOR NCL METHOD
#88DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#89Chimeric immunoreceptor useful in treating human cancers
#90Gelsolin stimulation of blood samples using gold particles
#91Peptides for active anti-cytokine immunization
#92Chimeric immunoreceptor useful in treating human cancers
#93Method and compositions using a chimeric antigen receptor for enhanced anti-tumor effector functioning of T cells
#94Peptides for active anti-cytokine immunization
#95Molecular Antigen Array
#96Molecular Antigen Array
#97Multi-level specific targeting of cancer cells with IL-13
#98Cysteine variants of interferon gamma
#99Chimeric immunoreceptor useful in treating human gliomas
#100Alteration of Fc-fusion protein serum half-lives by mutagenesis
#101Peptides for active anti-cytokine immunization
#102LIGATION OF STAPLED POLYPEPTIDES
#103Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents
#104Angiotensin peptide-carrier conjugates and uses thereof
#105Feline granulocyte macrophage colony stimulating factor proteins
#106Peptides for active anti-cytokine immunization
#107Nucleic acids encoding cynomolgus IL-13 mutein proteins
#108Cytokine-based fusion proteins for treatment of multiple sclerosis
#109Chimeric immunoreceptor useful in treating human cancers
#110Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
#111Targeting of herpes simplex virus to specific receptors
#112CANINE AND FELINE IMMUNOREGULATORY PROTEINS, NUCLEIC ACID MOLECULES, AND USES THEREOF
#113Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells
#114DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#115Methods for Reducing the Immunogenicity of Cytokines and Removal of Cell Surface Markers
#116Cysteine variants of interferon gamma
#117Alteration of Fc-fusion protein serum half-lives by mutagenesis
#118Molecular antigen arrary
#119Ligands and libraries of ligands
#120Peptides for active anti-cytokine immunization
#121Cysteine variants of interferon-gamma
#122Method for treating asthma and chronic obstructive pulmonary disease (COPD) comprising administering FGF2
#123Targeting of Herpes Simplex Virus to Specific Receptors
#124Canine IL-5 proteins and fragments thereof
#125Antigen arrays for treatment of bone disease
#126Antigen arrays for treatment of allergic eosinophilic diseases
#127Angiotensin peptide-carrier conjugates and uses thereof
#128Molecular antigen array
#129Feline granulocyte macrophage colony stimulating factor nucleic acid molecules
#130Peptides for active anti-cytokine immunization
#131Feline interferon-alpha proteins
#132Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
#133Angiotensin peptide-carrier conjugates and uses thereof
#134Chimeric immunoreceptor useful in treating human gliomas
#135Vaccine
#136DTAT fusion toxin
#137Cysteine substitution variants of beta interferon
#138Alteration of Fc-fusion protein serum half-lives by mutagenesis
#139COOH-terminally added cysteine variant of the beta interferon
#140IL-4/IL-13 specific polypeptides and therapeutic uses thereof
#141Vaccine
#142Chemically modified cytokines
#143Cysteine variants of erythropoietin
#144Cysteine variants of erythropoietin
#145Nucleic acids encoding IL13 mutants